Smoking tobacco cigarettes is associated with premature mortality. Quitting smoking can help people gain between 3 to 10 Quality Adjusted Life Years ( QALYs). However, even the best evidence based treatments have low absolute quit rates. Repeated attempts are associated with greater success and should be encouraged. Unfortunately, some populations such as those with concurrent addictions and or mental illness are "treatment resistant". This session will present emerging evidence on novel and new interventions ( eg brain stimulation) that could help them stop smoking cigarettes for good. In addition, this session will invite attendees to appraise the evidence for off-label use of existing treatments including combination, higher doses, extended treatment, and lower risk nicotine use guidelines.
Learning Objectives:
Learners will be able to:
Appraise novel interventions (pharmacological and neuromodulatory) for people who smoke and are resistant to current approved evidence based interventions.
